These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31678570)

  • 1. The utility of dried blood spot monitoring of branched-chain amino acids for maple syrup urine disease: A retrospective chart review study.
    Kaur J; Nagy L; Wan B; Saleh H; Schulze A; Raiman J; Inbar-Feigenberg M
    Clin Chim Acta; 2020 Jan; 500():195-201. PubMed ID: 31678570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved ultra performance liquid chromatography-tandem mass spectrometry method for the determination of alloisoleucine and branched chain amino acids in dried blood samples.
    Alodaib A; Carpenter K; Wiley V; Sim K; Christodoulou J; Wilcken B
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):468-70. PubMed ID: 21775576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
    Oglesbee D; Sanders KA; Lacey JM; Magera MJ; Casetta B; Strauss KA; Tortorelli S; Rinaldo P; Matern D
    Clin Chem; 2008 Mar; 54(3):542-9. PubMed ID: 18178665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
    Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
    Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
    Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
    Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.
    Schadewaldt P; Hammen HW; Ott AC; Wendel U
    J Inherit Metab Dis; 1999 Aug; 22(6):706-22. PubMed ID: 10472531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of liquid chromatography-tandem mass spectrometry in the diagnosis and follow-up of maple syrup urine disease in a Chinese population.
    Lin N; Ye J; Qiu W; Han L; Zhang H; Gu X
    J Pediatr Endocrinol Metab; 2013; 26(5-6):433-9. PubMed ID: 23412862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maple syrup urine disease: Clinical outcomes, metabolic control, and genotypes in a screened population after four decades of newborn bloodspot screening in the Republic of Ireland.
    O'Reilly D; Crushell E; Hughes J; Ryan S; Rogers Y; Borovickova I; Mayne P; Riordan M; Awan A; Carson K; Hunter K; Lynch B; Shahwan A; Rüfenacht V; Häberle J; Treacy EP; Monavari AA; Knerr I
    J Inherit Metab Dis; 2021 May; 44(3):639-655. PubMed ID: 33300147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Maple Syrup Urine Disease in Newborns.
    Harris-Haman P; Brown L; Massey S; Ramamoorthy S
    Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease.
    Parini R; Sereni LP; Bagozzi DC; Corbetta C; Rabier D; Narcy C; Hubert P; Saudubray JM
    Pediatrics; 1993 Aug; 92(2):280-3. PubMed ID: 8337030
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenylbutyrate therapy for maple syrup urine disease.
    Brunetti-Pierri N; Lanpher B; Erez A; Ananieva EA; Islam M; Marini JC; Sun Q; Yu C; Hegde M; Li J; Wynn RM; Chuang DT; Hutson S; Lee B
    Hum Mol Genet; 2011 Feb; 20(4):631-40. PubMed ID: 21098507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory Untargeted Metabolomics of Dried Blood Spot Samples from Newborns with Maple Syrup Urine Disease.
    Alotaibi AZ; AlMalki RH; Al Mogren M; Sebaa R; Alanazi M; Jacob M; Alodaib A; Alfares A; Abdel Rahman AM
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.
    Treacy E; Clow CL; Reade TR; Chitayat D; Mamer OA; Scriver CR
    J Inherit Metab Dis; 1992; 15(1):121-35. PubMed ID: 1583867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrodermatitis enteropathica-like eruption during treatment of maple syrup urine disease: report of one case.
    Tain YL; Huang SC; Hung FC; Wang HS; Sun PC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):357-60. PubMed ID: 8942030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maple syrup urine disease of neonates: report of two cases and review of literature].
    Chen Z; Luo F; Wu XJ; Shi LP
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):680-4. PubMed ID: 21092528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical maple syrup urine disease and brain development: principles of management and formula design.
    Strauss KA; Wardley B; Robinson D; Hendrickson C; Rider NL; Puffenberger EG; Shellmer D; Moser AB; Morton DH
    Mol Genet Metab; 2010 Apr; 99(4):333-45. PubMed ID: 20061171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.